Alberto Serrano-Pozo, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Alzheimer Disease | 43 | 2024 | 8037 | 4.180 |
Why?
|
Plaque, Amyloid | 19 | 2023 | 729 | 3.190 |
Why?
|
Astrocytes | 12 | 2022 | 1270 | 2.020 |
Why?
|
Microglia | 9 | 2024 | 1266 | 1.550 |
Why?
|
Neurofibrillary Tangles | 9 | 2023 | 439 | 1.550 |
Why?
|
Apolipoprotein E4 | 6 | 2023 | 668 | 1.400 |
Why?
|
Apolipoprotein E2 | 3 | 2021 | 127 | 1.290 |
Why?
|
Amyloid beta-Peptides | 18 | 2024 | 3585 | 1.240 |
Why?
|
Lewy Body Disease | 4 | 2024 | 229 | 1.030 |
Why?
|
Gliosis | 4 | 2024 | 245 | 0.870 |
Why?
|
Frontotemporal Dementia | 2 | 2024 | 248 | 0.800 |
Why?
|
Apolipoproteins E | 4 | 2021 | 1438 | 0.790 |
Why?
|
Receptors, GABA | 2 | 2022 | 288 | 0.790 |
Why?
|
Brain | 23 | 2024 | 26413 | 0.690 |
Why?
|
Aspartic Acid Endopeptidases | 2 | 2017 | 311 | 0.630 |
Why?
|
Nerve Degeneration | 2 | 2020 | 748 | 0.610 |
Why?
|
PubMed | 1 | 2017 | 123 | 0.560 |
Why?
|
tau Proteins | 8 | 2024 | 1868 | 0.550 |
Why?
|
Amyloid Precursor Protein Secretases | 2 | 2017 | 584 | 0.540 |
Why?
|
Amyloid beta-Protein Precursor | 4 | 2015 | 1121 | 0.530 |
Why?
|
Disease Progression | 4 | 2021 | 13280 | 0.480 |
Why?
|
Neurites | 3 | 2015 | 388 | 0.450 |
Why?
|
Bibliometrics | 1 | 2017 | 339 | 0.440 |
Why?
|
Cognition Disorders | 3 | 2016 | 4041 | 0.400 |
Why?
|
Apolipoprotein E3 | 4 | 2021 | 97 | 0.380 |
Why?
|
Immunohistochemistry | 9 | 2023 | 11368 | 0.360 |
Why?
|
Amyloidosis | 1 | 2016 | 795 | 0.340 |
Why?
|
Autopsy | 4 | 2019 | 1021 | 0.330 |
Why?
|
Temporal Lobe | 2 | 2015 | 1670 | 0.330 |
Why?
|
Genotype | 3 | 2021 | 12956 | 0.330 |
Why?
|
Neurons | 7 | 2020 | 9335 | 0.310 |
Why?
|
Simvastatin | 1 | 2010 | 360 | 0.300 |
Why?
|
Red Nucleus | 1 | 2007 | 10 | 0.300 |
Why?
|
Glial Fibrillary Acidic Protein | 3 | 2020 | 528 | 0.290 |
Why?
|
Brain Stem Infarctions | 1 | 2007 | 32 | 0.290 |
Why?
|
Neuroglia | 3 | 2023 | 927 | 0.280 |
Why?
|
Atrophy | 2 | 2024 | 1582 | 0.250 |
Why?
|
Vertebral Artery | 1 | 2005 | 192 | 0.250 |
Why?
|
Aged, 80 and over | 15 | 2021 | 57768 | 0.250 |
Why?
|
Leprosy | 1 | 2004 | 127 | 0.240 |
Why?
|
Infarction | 1 | 2005 | 246 | 0.240 |
Why?
|
Synapses | 4 | 2014 | 1729 | 0.230 |
Why?
|
Embolism | 1 | 2007 | 409 | 0.230 |
Why?
|
Polyneuropathies | 1 | 2004 | 139 | 0.230 |
Why?
|
Humans | 49 | 2024 | 744220 | 0.220 |
Why?
|
Mitochondria | 4 | 2024 | 3520 | 0.220 |
Why?
|
Aged | 21 | 2023 | 163253 | 0.220 |
Why?
|
Transcription, Genetic | 1 | 2017 | 7723 | 0.210 |
Why?
|
Longitudinal Studies | 4 | 2021 | 13990 | 0.210 |
Why?
|
Paraffin Embedding | 1 | 2023 | 299 | 0.200 |
Why?
|
Neurodegenerative Diseases | 2 | 2020 | 1062 | 0.200 |
Why?
|
Formaldehyde | 1 | 2023 | 353 | 0.190 |
Why?
|
Cholesterol | 1 | 2010 | 2911 | 0.190 |
Why?
|
Tauopathies | 2 | 2015 | 307 | 0.190 |
Why?
|
Biomedical Research | 1 | 2017 | 3311 | 0.190 |
Why?
|
Cerebral Amyloid Angiopathy | 2 | 2023 | 859 | 0.190 |
Why?
|
Spinal Diseases | 1 | 2005 | 538 | 0.190 |
Why?
|
Hippocampus | 3 | 2021 | 3676 | 0.180 |
Why?
|
Hypoxia-Inducible Factor 1 | 1 | 2021 | 198 | 0.180 |
Why?
|
Aging | 6 | 2021 | 8661 | 0.180 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2004 | 700 | 0.170 |
Why?
|
Cell Hypoxia | 1 | 2021 | 675 | 0.160 |
Why?
|
Spine | 1 | 2005 | 1145 | 0.160 |
Why?
|
Amyloid | 2 | 2015 | 795 | 0.160 |
Why?
|
Male | 25 | 2023 | 350027 | 0.160 |
Why?
|
Vaccination | 1 | 2010 | 3278 | 0.150 |
Why?
|
Alleles | 2 | 2021 | 6938 | 0.150 |
Why?
|
Cohort Studies | 5 | 2021 | 40559 | 0.140 |
Why?
|
Female | 23 | 2023 | 380197 | 0.140 |
Why?
|
Mice | 13 | 2024 | 81178 | 0.130 |
Why?
|
Gene Expression Profiling | 2 | 2023 | 9438 | 0.130 |
Why?
|
Animals | 17 | 2024 | 168788 | 0.130 |
Why?
|
Mice, Transgenic | 6 | 2017 | 9735 | 0.120 |
Why?
|
Mental Status Schedule | 1 | 2014 | 321 | 0.110 |
Why?
|
Adaptor Proteins, Vesicular Transport | 1 | 2015 | 315 | 0.110 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2017 | 627 | 0.110 |
Why?
|
Presenilin-1 | 2 | 2015 | 635 | 0.110 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2015 | 474 | 0.110 |
Why?
|
Spinal Cord | 1 | 2021 | 1809 | 0.110 |
Why?
|
Phenotype | 3 | 2023 | 16365 | 0.100 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2017 | 3871 | 0.100 |
Why?
|
Coronary Disease | 1 | 2007 | 6078 | 0.100 |
Why?
|
Inflammation Mediators | 1 | 2020 | 1889 | 0.100 |
Why?
|
Cell Count | 2 | 2013 | 1854 | 0.100 |
Why?
|
Tomography | 1 | 2013 | 390 | 0.100 |
Why?
|
Hydroxycholesterols | 1 | 2010 | 25 | 0.090 |
Why?
|
Neuropsychological Tests | 2 | 2013 | 6991 | 0.090 |
Why?
|
Age of Onset | 2 | 2020 | 3270 | 0.090 |
Why?
|
Protein Folding | 2 | 2014 | 843 | 0.090 |
Why?
|
Gene Expression | 3 | 2019 | 7799 | 0.090 |
Why?
|
Endothelial Cells | 2 | 2023 | 3478 | 0.090 |
Why?
|
Voltage-Dependent Anion Channel 1 | 1 | 2010 | 33 | 0.090 |
Why?
|
Transduction, Genetic | 1 | 2013 | 913 | 0.090 |
Why?
|
Positron-Emission Tomography | 2 | 2019 | 6274 | 0.090 |
Why?
|
Phosphorylation | 4 | 2020 | 8437 | 0.090 |
Why?
|
Energy Metabolism | 1 | 2020 | 2895 | 0.090 |
Why?
|
Risk Factors | 4 | 2024 | 72280 | 0.080 |
Why?
|
Computational Biology | 1 | 2021 | 3523 | 0.080 |
Why?
|
alpha-Synuclein | 1 | 2015 | 725 | 0.080 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2013 | 1475 | 0.080 |
Why?
|
Dependovirus | 1 | 2013 | 706 | 0.080 |
Why?
|
Dementia | 1 | 2022 | 2518 | 0.080 |
Why?
|
Proteomics | 1 | 2021 | 3637 | 0.080 |
Why?
|
Middle Aged | 9 | 2020 | 213367 | 0.080 |
Why?
|
Polyradiculoneuropathy | 1 | 2007 | 67 | 0.080 |
Why?
|
Neocortex | 1 | 2011 | 401 | 0.080 |
Why?
|
Ubiquitin | 1 | 2012 | 852 | 0.070 |
Why?
|
Microscopy, Confocal | 1 | 2013 | 1971 | 0.070 |
Why?
|
Calcium | 1 | 2020 | 5757 | 0.070 |
Why?
|
Mice, Inbred C57BL | 4 | 2020 | 21824 | 0.070 |
Why?
|
Magnetic Resonance Imaging | 3 | 2011 | 35423 | 0.070 |
Why?
|
Membrane Potential, Mitochondrial | 2 | 2020 | 297 | 0.070 |
Why?
|
Resilience, Psychological | 1 | 2013 | 675 | 0.070 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2012 | 1337 | 0.070 |
Why?
|
Guillain-Barre Syndrome | 1 | 2007 | 123 | 0.070 |
Why?
|
Vincristine | 1 | 2007 | 1036 | 0.060 |
Why?
|
Cognition | 3 | 2022 | 6765 | 0.060 |
Why?
|
Sural Nerve | 1 | 2004 | 112 | 0.060 |
Why?
|
Diagnosis, Differential | 5 | 2015 | 12961 | 0.060 |
Why?
|
Myocardial Infarction | 1 | 2005 | 11728 | 0.060 |
Why?
|
RNA, Messenger | 2 | 2017 | 13036 | 0.060 |
Why?
|
Aortography | 1 | 2005 | 437 | 0.060 |
Why?
|
Genetic Vectors | 1 | 2013 | 3420 | 0.060 |
Why?
|
Spain | 1 | 2004 | 465 | 0.060 |
Why?
|
Hypercholesterolemia | 1 | 2010 | 1151 | 0.060 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2013 | 6037 | 0.060 |
Why?
|
Neural Conduction | 1 | 2004 | 468 | 0.060 |
Why?
|
Solitary Nucleus | 1 | 2023 | 63 | 0.060 |
Why?
|
Anticholesteremic Agents | 1 | 2010 | 979 | 0.050 |
Why?
|
Oxidative Stress | 3 | 2024 | 3085 | 0.050 |
Why?
|
Prevalence | 1 | 2019 | 15226 | 0.050 |
Why?
|
Severity of Illness Index | 2 | 2020 | 15538 | 0.050 |
Why?
|
Entorhinal Cortex | 1 | 2023 | 272 | 0.050 |
Why?
|
Microscopy, Electron | 1 | 2004 | 2645 | 0.050 |
Why?
|
Case-Control Studies | 3 | 2013 | 21752 | 0.050 |
Why?
|
Age Factors | 1 | 2017 | 18367 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 2 | 2019 | 17449 | 0.040 |
Why?
|
Ultrasonography | 1 | 2012 | 5982 | 0.040 |
Why?
|
Myeloid Cells | 1 | 2024 | 809 | 0.040 |
Why?
|
Oxidative Phosphorylation | 1 | 2021 | 480 | 0.040 |
Why?
|
Algorithms | 2 | 2022 | 13885 | 0.040 |
Why?
|
Chest Pain | 1 | 2005 | 1114 | 0.040 |
Why?
|
Green Fluorescent Proteins | 2 | 2015 | 2088 | 0.040 |
Why?
|
Oxidation-Reduction | 1 | 2024 | 2187 | 0.040 |
Why?
|
Disease Models, Animal | 4 | 2024 | 18027 | 0.040 |
Why?
|
Cell Proliferation | 1 | 2013 | 10480 | 0.040 |
Why?
|
Inflammation | 2 | 2020 | 10634 | 0.040 |
Why?
|
Cytosol | 1 | 2020 | 901 | 0.040 |
Why?
|
Genetic Heterogeneity | 1 | 2020 | 733 | 0.040 |
Why?
|
Protein Transport | 2 | 2012 | 1989 | 0.030 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2013 | 15525 | 0.030 |
Why?
|
Antioxidants | 1 | 2024 | 1663 | 0.030 |
Why?
|
Retrospective Studies | 2 | 2014 | 77426 | 0.030 |
Why?
|
Dermoscopy | 1 | 2014 | 56 | 0.030 |
Why?
|
Natural Language Processing | 1 | 2022 | 1040 | 0.030 |
Why?
|
Cell Line | 2 | 2021 | 15999 | 0.030 |
Why?
|
Anatomy, Cross-Sectional | 1 | 2013 | 141 | 0.030 |
Why?
|
Antibodies, Monoclonal | 1 | 2010 | 9275 | 0.030 |
Why?
|
Spinal Cord Injuries | 1 | 2021 | 931 | 0.030 |
Why?
|
Matched-Pair Analysis | 1 | 2013 | 288 | 0.030 |
Why?
|
Biopsy | 1 | 2004 | 6757 | 0.030 |
Why?
|
Centrifugation, Density Gradient | 1 | 2012 | 313 | 0.030 |
Why?
|
Blotting, Western | 1 | 2020 | 5180 | 0.030 |
Why?
|
Frontotemporal Lobar Degeneration | 1 | 2012 | 99 | 0.030 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2014 | 1801 | 0.030 |
Why?
|
Multigene Family | 1 | 2015 | 1102 | 0.030 |
Why?
|
Brain Diseases | 1 | 2021 | 1564 | 0.020 |
Why?
|
Protein Binding | 2 | 2015 | 9392 | 0.020 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2013 | 713 | 0.020 |
Why?
|
Protein Structure, Quaternary | 1 | 2012 | 436 | 0.020 |
Why?
|
Evaluation Studies as Topic | 1 | 2013 | 1676 | 0.020 |
Why?
|
Immunoblotting | 1 | 2014 | 1682 | 0.020 |
Why?
|
Skin | 1 | 2004 | 4363 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2020 | 19227 | 0.020 |
Why?
|
Sequence Deletion | 1 | 2015 | 1526 | 0.020 |
Why?
|
Cerebral Cortex | 2 | 2020 | 5709 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2022 | 19907 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2015 | 1655 | 0.020 |
Why?
|
Young Adult | 1 | 2017 | 56436 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2014 | 2505 | 0.020 |
Why?
|
Presynaptic Terminals | 1 | 2012 | 302 | 0.020 |
Why?
|
Amyotrophic Lateral Sclerosis | 1 | 2020 | 1423 | 0.020 |
Why?
|
Peptide Fragments | 2 | 2012 | 5096 | 0.020 |
Why?
|
Transgenes | 1 | 2013 | 1009 | 0.020 |
Why?
|
Maze Learning | 1 | 2011 | 478 | 0.020 |
Why?
|
Brain Injuries | 1 | 2021 | 2025 | 0.020 |
Why?
|
Adolescent | 1 | 2017 | 85759 | 0.020 |
Why?
|
Conditioning, Classical | 1 | 2011 | 366 | 0.020 |
Why?
|
Paraparesis | 1 | 2007 | 14 | 0.020 |
Why?
|
Space Perception | 1 | 2011 | 475 | 0.020 |
Why?
|
Ubiquitination | 1 | 2012 | 1011 | 0.020 |
Why?
|
Protein Isoforms | 1 | 2012 | 1731 | 0.020 |
Why?
|
Daunorubicin | 1 | 2007 | 157 | 0.020 |
Why?
|
Terminology as Topic | 1 | 2014 | 1548 | 0.020 |
Why?
|
Paresthesia | 1 | 2007 | 162 | 0.020 |
Why?
|
Urination Disorders | 1 | 2007 | 241 | 0.020 |
Why?
|
Reference Values | 1 | 2013 | 4982 | 0.020 |
Why?
|
Electronic Health Records | 1 | 2022 | 4463 | 0.020 |
Why?
|
Cytarabine | 1 | 2007 | 692 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2012 | 2700 | 0.020 |
Why?
|
Qualitative Research | 1 | 2013 | 2682 | 0.020 |
Why?
|
Protein Conformation | 1 | 2012 | 4012 | 0.020 |
Why?
|
Medicare | 1 | 2022 | 6566 | 0.020 |
Why?
|
Transfection | 1 | 2012 | 5892 | 0.020 |
Why?
|
Psychometrics | 1 | 2013 | 3002 | 0.020 |
Why?
|
Adult | 2 | 2017 | 214035 | 0.020 |
Why?
|
Lipid Metabolism | 1 | 2012 | 1888 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2012 | 6367 | 0.010 |
Why?
|
Erectile Dysfunction | 1 | 2007 | 460 | 0.010 |
Why?
|
HEK293 Cells | 1 | 2012 | 4201 | 0.010 |
Why?
|
Prednisone | 1 | 2007 | 1575 | 0.010 |
Why?
|
Fatal Outcome | 1 | 2007 | 1849 | 0.010 |
Why?
|
Fear | 1 | 2011 | 1439 | 0.010 |
Why?
|
Remission Induction | 1 | 2007 | 2389 | 0.010 |
Why?
|
Memory | 1 | 2011 | 2174 | 0.010 |
Why?
|
Methotrexate | 1 | 2007 | 1720 | 0.010 |
Why?
|
Dexamethasone | 1 | 2007 | 1948 | 0.010 |
Why?
|
Action Potentials | 1 | 2007 | 1815 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2013 | 4044 | 0.010 |
Why?
|
Sex Factors | 1 | 2013 | 10396 | 0.010 |
Why?
|
Hydrocortisone | 1 | 2007 | 1826 | 0.010 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2007 | 1519 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2013 | 14556 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2015 | 12075 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2013 | 8950 | 0.010 |
Why?
|
United States | 1 | 2022 | 69867 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2007 | 11493 | 0.000 |
Why?
|